Cargando…
Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs
Evidence for beneficial effects of corticotropin releasing hormone (CRH) antagonists in abdominal and pelvic organs is emerging in preclinical studies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement a compilation of preclinical studies using CRH r...
Autores principales: | Pagán-Busigó, Joshua E., López-Carrasquillo, Jonathan, Appleyard, Caroline B., Torres-Reverón, Annelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916623/ https://www.ncbi.nlm.nih.gov/pubmed/35275963 http://dx.doi.org/10.1371/journal.pone.0264909 |
Ejemplares similares
-
Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis
por: Torres-Reverón, Annelyn, et al.
Publicado: (2018) -
Metabolomics in endometriosis: challenges and perspectives for future studies
por: Ortiz, Camila N, et al.
Publicado: (2021) -
On the role of corticotropin-releasing hormone receptors in anxiety and depression
por: Reul, Johannes M. H. M., et al.
Publicado: (2002) -
Pregnancy anxiety, placental corticotropin-releasing hormone and length of gestation
por: Ramos, Isabel F., et al.
Publicado: (2022) -
Loss of hypothalamic corticotropin-releasing hormone markedly reduces anxiety behaviors in mice
por: Zhang, Rong, et al.
Publicado: (2016)